Election delays new device law in New Zealand
This article was originally published in Clinica
The inconclusive outcome of New Zealand's October 12th general election combined with a severe legislative backlog is delaying progress on new medical device regulations. Until a coalition agreement can be reached, the country has a National Party caretaker government.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.